As CEO of an Israeli biotech startup focused on liver cancer treatment, I’ve spent years studying the global landscape of hepatocellular carcinoma (HCC) — the most common form of liver cancer and one of the world’s deadliest malignancies….
Israel’s Liver Cancer Fight Gets More Urgent
